ID: ALA5218897

Max Phase: Preclinical

Molecular Formula: C17H15N5O2S

Molecular Weight: 353.41

Associated Items:

Representations

Canonical SMILES:  N#Cc1c(NC(=O)CNc2onc3ncccc23)sc2c1CCCC2

Standard InChI:  InChI=1S/C17H15N5O2S/c18-8-12-10-4-1-2-6-13(10)25-17(12)21-14(23)9-20-16-11-5-3-7-19-15(11)22-24-16/h3,5,7,20H,1-2,4,6,9H2,(H,21,23)

Standard InChI Key:  CMFCQOPDASXQDA-UHFFFAOYSA-N

Associated Targets(Human)

NCI-H1299 3248 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 353.41Molecular Weight (Monoisotopic): 353.0946AlogP: 3.09#Rotatable Bonds: 4
Polar Surface Area: 103.84Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.23CX Basic pKa: CX LogP: 2.68CX LogD: 2.68
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -2.41

References

1. Duvauchelle V, Meffre P, Benfodda Z..  (2022)  Recent contribution of medicinally active 2-aminothiophenes: A privileged scaffold for drug discovery.,  238  [PMID:35696863] [10.1016/j.ejmech.2022.114502]

Source